{"member_organisations": "http://www.medicinesforeurope.com/medicines-for-europe/#section-5", "identification_number": "48325781850-28", "fields_of_interest": "General and Institutional Affairs, Economy, finance and the euro, Trade, Competition, Consumers, Customs, Enlargement, Business and Industry, Taxation, Single market, Research and innovation, Public Health, Digital economy and society", "head_office_address": "RUE D'ARLON, 50", "full_time_equivalent_fte": "2,25", "person_with_legal_responsibility": "Marc-Alexandre MAHL", "industry_forums": "", "grants": "", "country_code": "be", "inter_groups": "", "eu_initiatives": "Medicines for Europe plays an important consultative part in European healthcare policy-making and provides key educational role for its members. Medicines for Europe and its members work with European national governments and the EU institutions to develop sustainable solutions for pharmaceutical care and to increase Europe\u2019s competitive strength in the global pharmaceutical medicines market.", "level_of_interest": "European", "organisation_name": "MEDICINES FOR EUROPE (-)", "belgium_office_post_code": "", "number_of_persons_involved": "8", "person_in_charge_of_eu_relations": "Adrian Van den Hoven", "section": "II - In-house lobbyists and trade/business/professional associations", "lon": "4.37227703957173", "source": "", "subsection": "Trade and business associations", "belgium_office_phone": "", "overall_budget_turnover_as_a_range": "", "belgium_office_address": "", "persons_accredited_for_access_to_european_parliament_premises": "NAPOLITANO#Sergio, PENNISI#Giuliana, PUCCI#Andrea", "registration_date": "16/06/2009", "estimate_of_costs_absolute_amount": "", "website_address": "http://www.medicinesforeurope.com", "commission_expert_groups_and_other_similar_entities_european_commission": "Expert group on follow-up activities related to Corporate Responsibility in the field of Pharmaceuticals #E02558#http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=2558#Member#C#Strategic Coordination Group for the Water Framework and Floods Directives#E00371#http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=371#Not a member#C#Chemicals", "head_office_post_box": "", "head_office_city": "BRUSSELS", "membership": "\u2022    NGO status with World Health Organization (WHO) \n\u2022    Consultative status with World Intellectual Property Organization (WIPO) \n\u2022    Founding Member International Generic and Biosimilar Pharmaceutical Alliance (IGBA) \n\u2022    Member Federation of European and International Associations Established in Belgium (FAIB)", "head_office_post_code": "1000", "position": "DIRECTOR GENERAL", "financial_year_start_date": "01/01/2017", "head_office_country": "Belgium", "number_of_ep_accredited_persons": "3", "relevant_communication": "", "financial_year_end_date": "01/12/2017", "lat": "50.8400879", "estimate_of_costs_as_a_range": "300000-399999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "AISBL", "procurement": "", "customers": "", "belgium_office_post_box": "", "goals__remit": "Medicines for Europe represents the pharmaceutical companies supplying the largest share of medicines across Europe and is the voice of the generic, biosimilar and value added industries. As a leading partner for better healthcare, we aim to increase the health and wellbeing of all Europeans through better access to high quality medicines. Medicines for Europe members\u2019 portfolio cover 80% of therapy areas, and in so doing, safeguards the sustainability of Europe\u2019s healthcare systems for future generations.", "belgium_office_city": "", "head_office_phone": "(+32)2 736 84 11"}